Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 1
1948 10
1949 1
1950 2
1951 25
1952 62
1953 107
1954 136
1955 136
1956 141
1957 137
1958 139
1959 71
1960 2
1961 2
1963 12
1964 83
1965 377
1966 664
1967 860
1968 1085
1969 1205
1970 1282
1971 1482
1972 1638
1973 1843
1974 1830
1975 1628
1976 1517
1977 1452
1978 1463
1979 1541
1980 1608
1981 1732
1982 1876
1983 2111
1984 2375
1985 2491
1986 2419
1987 2410
1988 2341
1989 2727
1990 3195
1991 3294
1992 3224
1993 3563
1994 3809
1995 3658
1996 3926
1997 3997
1998 4216
1999 4183
2000 4851
2001 5061
2002 5609
2003 5816
2004 5838
2005 6363
2006 6804
2007 7167
2008 7411
2009 7873
2010 8541
2011 9147
2012 9505
2013 9733
2014 10132
2015 10166
2016 9962
2017 10333
2018 10407
2019 10780
2020 11091
2021 10465
2022 9633
2023 8805
2024 6973

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262,554 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hematopoietic and Lymphoid System Disorder"
Page 1
Manual lymphatic drainage for lymphedema following breast cancer treatment.
Ezzo J, Manheimer E, McNeely ML, Howell DM, Weiss R, Johansson KI, Bao T, Bily L, Tuppo CM, Williams AF, Karadibak D. Ezzo J, et al. Cochrane Database Syst Rev. 2015 May 21;2015(5):CD003475. doi: 10.1002/14651858.CD003475.pub2. Cochrane Database Syst Rev. 2015. PMID: 25994425 Free PMC article. Review.
SEARCH METHODS: We searched Medline, EMBASE, CENTRAL, WHO ICTRP (World Health Organization's International Clinical Trial Registry Platform), and Cochrane Breast Cancer Group's Specialised Register from root to 24 May 2013. ...This finding, however, needs to be conf …
SEARCH METHODS: We searched Medline, EMBASE, CENTRAL, WHO ICTRP (World Health Organization's International Clinical Trial Regi …
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials.
Verstovsek S, Mesa R, Gupta V, Lavie D, Dubruille V, Cambier N, Platzbecker U, Hus M, Xicoy B, Oh ST, Kiladjian JJ, Vannucchi AM, Gerds A, Egyed M, Mayer J, Sacha T, Kawashima J, Morris M, Huang M, Harrison C. Verstovsek S, et al. Blood Adv. 2023 Jul 25;7(14):3582-3591. doi: 10.1182/bloodadvances.2022009311. Blood Adv. 2023. PMID: 37042865 Free PMC article.
This long-term analysis pooled data from 3 randomized phase 3 studies of momelotinib (MOMENTUM, SIMPLIFY-1, and SIMPLIFY-2), representing MF disease from early (JAK inhibitor-naive) to late (JAK inhibitor-experienced) stages. ...This analysis of one of the largest rando …
This long-term analysis pooled data from 3 randomized phase 3 studies of momelotinib (MOMENTUM, SIMPLIFY-1, and SIMPLIFY-2), represen …
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
Rajkumar SV, Harousseau JL, Durie B, Anderson KC, Dimopoulos M, Kyle R, Blade J, Richardson P, Orlowski R, Siegel D, Jagannath S, Facon T, Avet-Loiseau H, Lonial S, Palumbo A, Zonder J, Ludwig H, Vesole D, Sezer O, Munshi NC, San Miguel J; International Myeloma Workshop Consensus Panel 1. Rajkumar SV, et al. Blood. 2011 May 5;117(18):4691-5. doi: 10.1182/blood-2010-10-299487. Epub 2011 Feb 3. Blood. 2011. PMID: 21292775 Free PMC article.
It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The goal of the International Myeloma Workshop Consensus Panel 1 was to develop a set of guidelines for the uniform reporting of clinical …
It is essential that there be consistency in the conduct, analysis, and reporting of clinical trial results in myeloma. The go …
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, Schiffer CA, Doehner H, Tallman MS, Lister TA, Lo-Coco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Löwenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD; International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. Cheson BD, et al. J Clin Oncol. 2003 Dec 15;21(24):4642-9. doi: 10.1200/JCO.2003.04.036. J Clin Oncol. 2003. PMID: 14673054
Advances in myelodysplastic syndrome.
Santini V. Santini V. Curr Opin Oncol. 2021 Nov 1;33(6):681-686. doi: 10.1097/CCO.0000000000000790. Curr Opin Oncol. 2021. PMID: 34474438 Review.
PURPOSE OF REVIEW: In this review, the focus is on the most recent improvements in diagnosis, prognostication and therapy of myelodysplastic syndromes (MDS) and on their relevance for clinical management. RECENT FINDINGS: Analytical methods to refine cytogenetic and molecu …
PURPOSE OF REVIEW: In this review, the focus is on the most recent improvements in diagnosis, prognostication and therapy of myelodysplastic …
Rethinking clinical trial endpoints in myelodysplastic syndromes.
Sekeres MA, Steensma DP. Sekeres MA, et al. Leukemia. 2019 Mar;33(3):570-575. doi: 10.1038/s41375-018-0367-7. Epub 2019 Jan 30. Leukemia. 2019. PMID: 30700839 Review.
The myelodysplastic syndromes (MDS) are a heterogeneous collection of clonal, hematopoietic disorders primarily affecting an older population, making successful drug development a complicated process. ...We review challenges in drug development in MDS with respect to align …
The myelodysplastic syndromes (MDS) are a heterogeneous collection of clonal, hematopoietic disorders primarily affecting an older po …
Gene Therapy for Hemophilia.
Nienhuis AW, Nathwani AC, Davidoff AM. Nienhuis AW, et al. Hum Gene Ther. 2016 Apr;27(4):305-8. doi: 10.1089/hum.2016.018. Hum Gene Ther. 2016. PMID: 27021603 Review.
The trial that we conducted with our collaborators has yielded evidence of clinical efficacy for hemophilia B. A vector for treating hemophilia A has been developed and a clinical trial is planned....
The trial that we conducted with our collaborators has yielded evidence of clinical efficacy for hemophilia B. A vector for tr …
Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies.
Garcia-Manero G, Döhner H, Wei AH, La Torre I, Skikne B, Beach CL, Santini V. Garcia-Manero G, et al. Clin Lymphoma Myeloma Leuk. 2022 Apr;22(4):236-250. doi: 10.1016/j.clml.2021.09.021. Epub 2021 Oct 8. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34758945 Free article. Review.
Effective maintenance therapy has long been a goal for patients with AML in remission. Previous large, randomized clinical trials of maintenance with HMAs or other agents had not shown meaningful improvement in overall survival. Oral azacitidine (Oral-AZA [CC-486]) …
Effective maintenance therapy has long been a goal for patients with AML in remission. Previous large, randomized clinical tri …
Epidemiology and treatment of priapism in sickle cell disease.
Idris IM, Burnett AL, DeBaun MR. Idris IM, et al. Hematology Am Soc Hematol Educ Program. 2022 Dec 9;2022(1):450-458. doi: 10.1182/hematology.2022000380. Hematology Am Soc Hematol Educ Program. 2022. PMID: 36485155 Free PMC article. Review.
Only 3 randomized clinical trials (stilbesterol, ephedrine or etilefrine, and sildenafil) have been conducted for secondary priapism prevention in SCD. ...We posit an increase in NO levels will restore the normal homeostatic relationship between voluntary erection a …
Only 3 randomized clinical trials (stilbesterol, ephedrine or etilefrine, and sildenafil) have been conducted for secondary pr …
Hedgehog signaling inhibitors in solid and hematological cancers.
Cortes JE, Gutzmer R, Kieran MW, Solomon JA. Cortes JE, et al. Cancer Treat Rev. 2019 Jun;76:41-50. doi: 10.1016/j.ctrv.2019.04.005. Epub 2019 May 6. Cancer Treat Rev. 2019. PMID: 31125907 Free article. Review.
DESIGN: Published literature was searched to identify articles relating to HHIs in noncutaneous cancer. Both preclinical and clinical research articles were included. In addition, relevant clinical trial results were identified from www.clinicaltrials.gov. .. …
DESIGN: Published literature was searched to identify articles relating to HHIs in noncutaneous cancer. Both preclinical and clinical …
262,554 results
You have reached the last available page of results. Please see the User Guide for more information.